Jason Gentle

Jason joined LifeSci in July 2022, developing broad expertise in commercial opportunity assessments and transaction advisory. Before LifeSci, Jason interned for a biotechnology startup, where he identified and utilized bioinformatic data to construct cancer proteomic databases. Jason earned a B.S. in Molecular and Medical Microbiology as well as a B.A. in Economics from the University of California, Davis.